WHO in Syria
Norway lends first-hand support to WHO in response to the cholera outbreak in Syria
Responding to the cholera outbreak in Syria, WHO delivered a 60-tonne shipment of cholera kits, oral rehydration solutions, rapid diagnostic tests, and medical supplies for intravenous (IV) rehydration treatment, in addition to chlorine for water purification4 October 2022, Damascus – Funding from Norway has enabled WHO to immediately respond to...
Update on COVID-19 vaccination in Syria, 22 August 2022
Summary As of 22 August 2022, the total number of COVID-19 vaccines delivered to Syria through the COVAX Facility is 11 357 640 doses in addition to the 2 953 640 doses received through bilateral agreements. The available vaccines should enable Syria to reach more than 45% of its population. Trends in COVID-19 vaccination coverage at the Whole of...
WHO and UDER implement multi-partner project to boost primary health care services in northwest Syria
16 August 2022 – WHO, together with the Relief Experts Association UDER as implementing agency, has bolstered the provision of primary health care services in northwest Syria by rendering the facilities in the towns of Sarmada, Tarmanin, Daret Azza and Zarzour fully operational. Due to the size and scope of the project – which took place between...
WHO conducts workshop in Gaziantep on measles surveillance and outbreak response in north-west Syria
4 August 2022 - In response to the ongoing measles outbreak in north-west Syria (NWS), the World Health Organization’s Regional Office for the Eastern Mediterranean and its Gaziantep Field Office in Türkiye organized a measles surveillance and outbreak response workshop joined by 35 participants from WHO’s surveillance and immunization...
Italy bolsters WHO efforts to enhance COVID-19 vaccination in Syria
Damascus, 2 August 2022 – Italy has contributed 2 million euros to the World Health Organization to support efforts to vaccinate 40% of the targeted population in Syria by the end of 2022. A number of interventions have so far been implemented at the national level to accelerate COVID-19 vaccination in Syria, including national vaccination...
WHO mobile clinics combat TB in Syria with Global Fund and IOM support
A WHO-supported mobile clinic provides free-of-charge services to people who suspect they may have TB Damascus, 7 July 2022 – WHO, the Global Fund and the International Organization for Migration (IOM) have been working closely to address HIV and tuberculosis (TB) epidemics under the Middle East Response (MER) project. Through the MER 1 grant, WHO...
Kuwait’s support gives a glimpse of hope for cancer patients in Syria
9 June, Damascus - Hamed, a 12-year-old boy from Idleb, Saraqeb, was diagnosed with cancer 3 months ago after getting injured while playing football. “It all came out of sudden. I was unintentionally hit by one of my friends while playing at the backyard of my home. I was in so much pain and could not move my leg. My parents took me to the...
Coastal areas in Syria take the COVID-19 vaccination campaign to a new level
Damascus, 8 June 2022 – In a bid to increase the COVID-19 vaccination rates, Syria completed a 2-week intensified national campaign targeting over 2.5 million people across the country. Through more than 1000 fixed centres and 400 mobile teams, the campaign reached nearly every remote area in Syria to bring the vaccines closer to people. In the...
WHO issues situation report calling for urgent action to address malnutrition in northeast Syria
18 May 2022 – Seven hundred thousand more children face hunger in Syria due to the country’s continuously deteriorating economy, especially in northeast Syria. In the last 6 months, the total number of food-insecure children across the country has risen to more than 4.6 million. After more than 10 years of conflict and displacement, an...
COVAX supply update on COVID-19 vaccination in Syria, 10 May 2022
Summary As of 9 May 2022, the total number of COVID-19 vaccines delivered to Syria through the COVAX Facility is 11 347 640 doses, in addition to 2 763 640 doses received through bilateral agreements. The available doses will enable Syria to reach about 45.4% of the population. Between 23 March and 4 April 2022, 1 043 700 doses of AstraZeneca...









